SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Dahl, L. K., Knudsen, K. D. & Iwai, J. (1969) Humoral transmission of hypertension: evidence from parabiosis, Circ. Res. 24/25 (Suppl. 1), 121131.
  • 2
    Greenberg, S. G., Gaines, K. & Sweatt, D. (1981) Evidence for circulating factors as cause of venous hypertrophy in SHR, Am. J. Physiol. 241, H421H430.
  • 3
    Hirata, Y., Tobian, L., Simon, G. & Iwai, J. (1984) Hypertension producing factor in serum of hypertensive Dahl salt sensitive rats, Hypertension 6, 709716.
  • 4
    Wright, G. L. & McCumbee, W. D. (1984) A hypertensive substance found in the blood of SHR, Life Sci. 34, 15211528.
  • 5
    Zidek, W., Heckmann, U., Lange-Aschenfeld, H., Losse, H. & Vetter, H. (1985) Humoral factors in the pathogenesis of primary hypertension, Klin. Wochenschr. 63, 9496.
  • 6
    McCumbee, W. D. & Wright, G. L. (1985) Partial purification of a hypertensive substance from rat erythrocytes, Can J. Physiol. Pharmacol. 63, 13211326.
  • 7
    Mathews, W. R. M., DuCharme, D. W., Hamlyn, J. M., Harris, D. W., Mandel, F., Clark, M. A. & Ludens, J. H. (1991) Mass spectral characterisation of an endogeneous digitalislike factor from human plasma, Hypertension 17, 930935.
  • 8
    Lewanczuk, R. Z., Chen, A. & Pang, P. K. T. (1990) The effects of dietary calcium on blood pressure in spontaneously hypertensive rats may be mediated by parathyroid hypertensive factor, Am. J. Hypertension 3, 349353.
  • 9
    Zidek, W., Heckmann, U., Losse, H. & Vetter, H. (1986) Effects on blood pressure of cross circulation between spontaneously hypertensive and normotensive rats, Clin. Exp. Hypertension A8, 347354.
  • 10
    Benishin, C. G., Lewanczuk, R. Z. & Pang, P. K. T. (1991) Purification of parathyroid hypertensive factor from plasma of spontaneously hypertensive rats, Proc. Natl Acad. Sci. USA 88, 63726376.
  • 11
    Staiger, C. H., Uebis, V. & Kaufmann, B. (1986) Dose-range finding study on BM13.505, a new thromboxane A2 receptor antagonist, in healthy volunteers, Naunyn-Schmiedebergs Arch. Pharmacol. 33, R97 (abstr.).
  • 12
    Stegmeier, K., Pill, J. & Patscheke, H. (1986) BM13.505, a selective and potent thromboxane A2 receptor antagonist, Naunyn-Schmiedebergs Arch. Pharmacol. 332, R36 (abstr.).
  • 13
    Yanagisawa, A., Smith, J. A. & Brezinski, M. E. (1987) Mechanism of antagonism of thromboxane receptors in vascular smooth muscle, Eur. J. Pharmacol. 133, 8996.
  • 14
    Pettersson, A., Gradin, K. & Hedner, T. (1985) Antihypertensive mechanism of action of ketanserin and some ketanserin analogues in the SHR, Naunyn-Schmiedebergs Arch. Pharmacol. 329, 394397.
  • 15
    Zidek, W., Ottens, E. & Heckmann, U. (1989) Transmission of hypertension in rats by cross-circulation, Hypertension 14, 6165.
  • 16
    Hofbauer, K. G., Zschiedrich, H. & Rauh, W. (1973) Conversion of angiotensin I into angiotensin II in the isolated perfused rat kidney, Clin. Sci. 44, 447456.
  • 17
    Hamlyn, J. M., Ringel, R., Schaeffer, J., Levinson, P. D., Hamilton, B. P., Kovarski, A. A. & Blaustein, M. P. (1982) A circulating inhibitor of Na/K-ATPase associated with essential hypertension, Nature 300, 650652.
  • 18
    Hillenkamp, F. & Karas, M. (1990) Mass spectrometry of peptides and proteins by matrix assisted ultraviolet laser desorption/ionization, Methods Enzymol. 193, 263279.
  • 19
    Neusser, M., Tepel, M. & Zidek, W. (1993) Erythropoietin increases cytosolic free calcium concentration in vascular smooth muscle cells, Cardiovasc. Res. 27, 12331236.
  • 20
    Tepel, M., Wischniowski, H. & Zidek, W. (1992) Erythropoietin-induced transmembrane calcium influx in essential hypertension, Life Sci 51, 161167.
  • 21
    Grynkiewicz, G., Poenie, M. & Tsien, R. Y. (1985) A new generation of Ca2+ indicators with greatly improved fluorescence properties, J. Biol. Chem. 260, 34403450.
  • 22
    McMurtry, J. P., Wright, G. L. & Wexler, B. C. (1981) Spontaneous hypertension in cross suckled rats, Science 211, 11731175.
  • 23
    Wright, G. L., Rogerson, M. E. & McCumbee, W. D. (1986) Stimulation of aortic tissue calcium uptake by an extract of SHR erythrocytes possessing hypertensive properties, Can. J. Physiol. Pharmacol. 64, 15151520.
  • 24
    Mizukoshi, H. & Michelakis, A. M. (1972) Evidence for the existence of a sensitizing factor to pressor agents in the plasma of hypertensive patients, J. Clin. Endocrinol. Metab. 34, 10161024.
  • 25
    Capuccio, F. P., Sagnella, G. A., Leathard, H. L., Markandu, N. D. & MacGregor, G. A. (1986) Evidence using human arterial tissue for a circulating vascular sensitizing agent in essential hypertension, J. Clin. Endocrinol. Metab. 63, 463467.
  • 26
    Yanagisawa, M., Kurihara, H. & Kimura, S. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells, Nature 332, 411415.
  • 27
    Richard, S., Neveu, D., Carnac, G., Bodin, P., Travo, P. & Nargeot, J. (1992) Differential expression of voltage-gated Ca2+-currents in cultivated aortic myocytes, Biochim. Biophys. Acta 1160, 95104.
  • 28
    Andrea, J. E. & Walsh, M. P. (1992) Protein kinase C of smooth muscle, Hypertension 20, 585595.